Shao Kang Wang

Chief Executive Officer at Infervision Medical Technology Co., Ltd.

36 year

Consumer Services

Technology Services

Profile

Shao Kang Wang is currently the Executive Director & General Manager at Infervision Medical Technology Co., Ltd.
and a Member-Supervisory Board at Shanghai Infervision Biotechnology Co. Ltd.
He graduated from The University of Chicago in 2012 with a graduate degree and from Beijing Institute of Technology in 2010 with an undergraduate degree.

Shao Kang Wang active positions

Companies	Position	Start
Infervision Medical Technology Co., Ltd. Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China.	Chief Executive Officer	2016-01-04
Shanghai Infervision Biotechnology Co. Ltd.	Director/Board Member	2019-12-31

All active positions of Shao Kang Wang

Training of Shao Kang Wang

The University of Chicago	Graduate Degree
Beijing Institute of Technology	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shao Kang Wang's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Infervision Medical Technology Co., Ltd. Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China.	Technology Services
Shanghai Infervision Biotechnology Co. Ltd.